World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
26106
World Ranking
17021
National Ranking
8536

Mark T. Dransfield publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark T. Dransfield sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 606 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark T. Dransfield D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark T. Dransfield sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark T. Dransfield is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on pulmonary and respiratory medicine, with significant contributions within the field of medicine overall. The subfields of study in which they are active include pulmonary and respiratory medicine, physiology, cardiology and cardiovascular medicine, epidemiology, and public health, environmental and occupational health.

The main topics covered by Dransfield's research include:

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Pulmonary Hypertension Research and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Their recent significant papers include:

  • Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission, 2022, The Lancet
  • Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults, 2021, JAMA
  • Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease, 2020, American Journal of Respiratory and Critical Care Medicine
  • Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults, 2020, JAMA
  • Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life, 2020, European Journal of Internal Medicine

Dransfield has frequently collaborated with a core group of co-authors including MeiLan K. Han, Gerard J. Criner, Fernando J. Martínez, Prescott G. Woodruff, and Nadia N. Hansel. Their partnerships reflect ongoing research efforts in respiratory medicine and related fields.

Their publications are prominently featured in several journals related to respiratory medicine, such as:

  • American Journal of Respiratory and Critical Care Medicine
  • CHEST Journal
  • Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
  • Annals of the American Thoracic Society
  • European Respiratory Journal

Best Publications

  • Azithromycin for Prevention of Exacerbations of COPD

    Richard K. Albert;Richard K. Albert;John Connett;William C. Bailey;Richard Casaburi

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

    David A. Lipson;Frank Barnhart;Noushin Brealey;Jean Brooks

  • Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

    Steven Pascoe;Nicholas Locantore;Mark T Dransfield;Mark T Dransfield;Neil C Barnes;Neil C Barnes

  • Pulmonary arterial enlargement and acute exacerbations of COPD.

    J. Michael Wells;George R. Washko;Mei Lan K. Han;Naseer Abbas

  • Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

    Mark T Dransfield;Jean Bourbeau;Paul W Jones;Nicola A Hanania

  • Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD

    G. J. Criner;John E Connett;S. D. Aaron;R. K. Albert

  • Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

    Gerard J. Criner;Jean Bourbeau;Rebecca L. Diekemper;Daniel R. Ouellette

  • Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.

    Kristopher R. Genschmer;Derek W. Russell;Charitharth Lal;Tomasz Szul

  • Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease

    Surya P. Bhatt;Xavier Soler;Xin Wang;Susan Murray

  • Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

    MeiLan K Han;Pedro M Quibrera;Elizabeth E Carretta;R Graham Barr

  • A Multicenter RCT of Zephyr® Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)

    Gerard J Criner;Richard Sue;Shawn Wright;Mark Dransfield

  • A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM)

    Gerard J. Criner;Richard Sue;Shawn Wright;Mark Dransfield

  • GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

    MeiLan K. Han;Hana Muellerova;Douglas Curran-Everett;Mark T. Dransfield

  • Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.

    Annette T Hastie;Fernando J Martinez;Jeffrey L Curtis;Claire M Doerschuk

  • Chronic obstructive pulmonary disease and cardiovascular disease

    Surya P. Bhatt;Mark T. Dransfield;Mark T. Dransfield

  • Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease

    Mark T. Dransfield;Mark T. Dransfield;Ken M. Kunisaki;Ken M. Kunisaki;Matthew J. Strand;Antonio Anzueto;Antonio Anzueto

  • Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial

    Frank C. Sciurba;Gerard J. Criner;Charlie Strange;Pallav L Shah

  • Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.

    Mark T Dransfield;Steven M Rowe;James E Johnson;William C Bailey

  • Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.

    Ken M. Kunisaki;Ken M. Kunisaki;Mark T. Dransfield;Mark T. Dransfield;Julie A. Anderson;Robert D. Brook

Frequent Co-Authors

MeiLan K. Han
MeiLan K. Han University of Michigan–Ann Arbor
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Gerard J. Criner
Gerard J. Criner Temple University
George R. Washko
George R. Washko Brigham and Women's Hospital
Nadia N. Hansel
Nadia N. Hansel Johns Hopkins University
Eric A. Hoffman
Eric A. Hoffman University of Iowa
Jeffrey L. Curtis
Jeffrey L. Curtis University of Michigan–Ann Arbor
Prescott G. Woodruff
Prescott G. Woodruff University of California, San Francisco
Robert A. Wise
Robert A. Wise Johns Hopkins University School of Medicine
Russell P. Bowler
Russell P. Bowler Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in pursuing a medical career but prefer flexible learning options, a range of online healthcare degrees can set you on the right path. Today, many reputable universities offer programs tailored to working adults or those seeking a more affordable entry into healthcare professions.

For those considering leadership roles in healthcare, affordable mha online programs offer practical knowledge in management, finance, and systems operations—key skills for hospital and clinic administrators. Alternatively, nurses aiming for the highest clinical credentials can explore cheapest dnp programs to advance into leadership or specialized clinical roles.

Pharmacy professionals looking to further their education can benefit from online pharmacy school programs designed to combine clinical expertise with business acumen. Meanwhile, those interested in the intersection of data and healthcare may find a bachelor of health information management online to be a stepping stone toward careers in health informatics or medical records management.

Each of these online programs offers a way to join or advance in the healthcare field while balancing life’s other commitments. Explore these options to discover the pathway that best matches your professional goals.

Best Scientists Citing Mark T. Dransfield

Trending Scientists

Recently Published Articles